Jens Erik S.
- Country
- Norway
- Department
- Department of oncology
Research Overview
- Phase 3 Randomized Study of INCB161734 Plus Combination Chemotherapy Versus Placebo Plus Chemotherapy in KRAS G12D‑Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3 Randomized Trial of Daraxonrasib Monotherapy or Daraxonrasib + Gemcitabine/Nab‑Paclitaxel vs Gemcitabine/Nab‑Paclitaxel in First‑Line Metastatic Pancreatic Cancer
- Evaluation of Clopidogrel and Dalteparin Sodium in Thromboprophylaxis for Pancreatic Ductal Adenocarcinoma Patients: A Randomized Clinical Trial
Data & Insights
Has run more than one trial at 40 of 128 partner sites.
Specializations
Hematologic Malignancies
Focused investigation of malignant blood disorders such as Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, and Mantle Cell Lymphoma.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Mantle Cell Lymphoma
Research includes evaluation of targeted agents and cellular therapies.
Solid Tumor Oncology
Broad oncology program targeting major solid cancers, including Non‑Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer, Clear Cell Renal Cell Carcinoma, and Pancreatic Ductal Adenocarcinoma.
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Clear Cell Renal Cell Carcinoma
- Pancreatic Ductal Adenocarcinoma
Studies integrate immunotherapy with conventional regimens.
Neuro‑Oncology and CNS Disorders
Specialized work on central nervous system malignancies and neurodegenerative diseases, such as Glioblastoma, Medulloblastoma, Neuroblastoma, Alzheimer’s Disease, and Amyotrophic Lateral Sclerosis.
- Glioblastoma
- Medulloblastoma
- Neuroblastoma
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
Investigations address blood‑brain barrier penetration and disease‑modifying strategies.
Cardiovascular and Metabolic Disease
Research addressing heart and metabolic health, including Chronic Heart Failure, Atrial Fibrillation, Type 2 Diabetes Mellitus, Obesity, and Takotsubo Syndrome.
- Chronic Heart Failure
- Atrial Fibrillation
- Type 2 Diabetes Mellitus
- Obesity
- Takotsubo Syndrome
Trials assess novel anticoagulants and metabolic modulators.
Immunology and Rare Hematologic Disorders
Dedicated investigations of immune‑mediated and rare blood conditions such as Autoimmune Cytopenias, Fetal and Neonatal Alloimmune Thrombocytopenia, Langerhans Cell Histiocytosis, Primary Immunoglobulin A Nephropathy, and Thyroid Eye Disease.
- Autoimmune Cytopenias
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Langerhans Cell Histiocytosis
- Primary Immunoglobulin A Nephropathy
- Thyroid Eye Disease
Efforts include biologic agents and precision‑medicine approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.